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Abstract
Background: Understanding how lineage choices are made during embryonic stem (ES) cell
differentiation is critical for harnessing strategies for controlled production of therapeutic somatic
cell types for cell transplantation and pharmaceutical drug screens. The in vitro generation of
dopaminergic neurons, the type of cells lost in Parkinson's disease patients' brains, requires the
inductive molecules sonic hedgehog and FGF8, or an unknown stromal cell derived inducing activity
(SDIA). However, the exact identity of the responding cells and the timing of inductive activity that
specify a dopaminergic fate in neural stem/progenitors still remain elusive.
Results: Using ES cells carrying a neuroepithelial cell specific vital reporter (Sox1-GFP) and FACS
purification of Sox1-GFP neural progenitors, we have investigated the temporal aspect of SDIA
mediated dopaminergic neuron specification during ES cell differentiation. Our results establish that
SDIA induces a dopaminergic neuron fate in nascent neural stem or progenitor cells at, or prior to,
Sox1 expression and does not appear to have further instructive role or neurotrophic activity
during late neuronal differentiation of neural precursors. Furthermore, we show that dopaminergic
neurons could be produced efficiently in a monolayer differentiation paradigm independent of SDIA
activity or exogenous signalling molecules. In this case, the competence for dopaminergic neuron
differentiation is also established at the level of Sox1 expression.
Conclusion: Dopaminergic neurons are specified early during mouse ES cell differentiation. The
subtype specification seems to be tightly linked with the acquisition of a pan neuroectoderm fate.
Background
Understanding how lineage progenitors are specified to
give rise to distinct somatic cell types is fundamental for
devising strategies for controlled differentiation of stem
cells. It is generally believed that during in vitro differen-
tiation, embryonic stem (ES) cell-derived neural stem cell/
progenitors acquire a dorsal-ventral and anterior-poste-
rior regional identity in a similar fashion to that of neu-
roepithelial stem cells in the developing embryo. Distinct
regional identity, as demonstrated by the expression of a
range of transcription factors, could be established by
developmental key morphogens such as sonic hedgehog
(SHH), bone morphogenic proteins (BMPs), and retinoic
acid (RA) [1-4]. For example, SHH and FGF8 have been
wildly used as inducers for generating dopaminergic neu-
rons whilst RA is employed to direct motorneuron pro-
duction from ES cells [2,4-6]. These inductive molecules
are generally applied at the time when neural progenitor
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production (ie. nestin+, Sox1+ cells) is at its peak. These
studies might imply that the morphogens such as Shh and
FGF8 act on ES cell-derived nestin+, Sox1+ neural progen-
itors to impose a regional identity. However, due to the
heterogeneous nature of ES cell in vitro differentiation,
one can not firmly pin point the identity of the responsive
cells. Furthermore, neural fate acquisition from ES cells in
vitro can occur much more quickly than in vivo during
development [7-9], implying that patterning during ES
cell differentiation may not fully recapitulate embryo
development.
In addition to Shh and FGF8, unknown inductive mole-
cules that are produced by stromal or other cell lines have
also been exploited to direct lineage specific differentia-
tion [10-12]. For example, dopaminergic neurons can be
induced by co-culturing ES cells with bone marrow
derived stromal cells such as PA6 that exhibit stromal cell-
derived inducing activity (SDIA; [10]). However, at which
stage of ES cell differentiation SDIA acts, and to what
extent regional identity is acquired intrinsically in this
model system and other ES cell differentiation paradigms
remains largely unknown.
We have previously developed an ES cell model system
that allows visualization and identification of neural stem
cells/progenitors during ES cell differentiation by knock-
ing in a GFP reporter into the Sox1 locus [13]. During ES
cell differentiation, Sox1-GFP is detected earlier than nes-
tin in ES cell-derived neural progenitors [14], thus provid-
ing a valuable tool to purify these cells from
undifferentiated ES cells and non-neural cell types by flu-
orescence activated cell sorting (FACS). In this study, we
utilize the Sox1-GFP model system in combination with
either PA6 co-culture or monolayer ES cell neuronal dif-
ferentiation in order to investigate the temporal aspects of
dopaminergic specification during ES cell differentiation.
We provide evidence that SDIA promotes dopaminergic
fate specification in neural progenitors at or prior to Sox1
expression and that SDIA does not appear to have further
instructive role or neurotrophic activity during neuronal
differentiation of neural precursors. Furthermore, our
work suggests that dopaminergic specification can occur
efficiently independent of SDIA activity and similarly at
the level of Sox1 expression, suggesting that early specifi-
cation is a general feature of dopaminergic differentiation
from mouse ES cells.
Results
Dopaminergic specification occurs early during ES cell 
differentiation
In order to address the question whether SDIA acts on
neural progenitors before or after the expression of Sox1,
we exploited the Sox1-GFP reporter ES cells in combina-
tion with neural differentiation via co-culture with PA6
stromal cells. Sox1-GFP expressing neural progenitor cells
were generated and purified by FACS sorting (Fig 1A–B,
E). Most experiments were performed at day 7 of differen-
tiation when the numbers of GFP expressing cells peaks
(59 ± 6%). FACS sorted GFPpos and GFPneg cell popula-
tions, together with reconstituted mixed cultures as con-
trol cells, were collected and re-plated in parallel. The cells
were plated either back on a layer of PA6 stromal cells or
on PDL/laminin coated plastic in N2/B27, in the absence
of exogenous growth factors (See flow scheme Fig. 1F, G).
Following an additional 7 days of differentiation, cultures
were examined for the presence of TH expressing neurons
by immunocytochemical staining (Fig. 2A–C).
When the GFPpos and GFPneg populations were mixed
again after sorting and plated back onto PA6 cells, they
gave rise to TH positive neurons at a frequency of 27 ± 7%.
This frequency is indistinguishable from that of unsorted
parallel control cultures (28 ± 4%, Fig. 3A), verifying that
the sorting procedure itself had no adverse effect on sub-
sequent dopaminergic differentiation. Therefore, we used
unsorted cultures as controls in subsequent experiments.
The GFPneg population, which consists mostly of cells of
non-neural lineage and a minority of undifferentiated ES
cells, rarely give rise to TH expressing neurons in the sub-
sequent 7 day differentiation culture regardless of the re-
plating condition after sorting (data not shown), consist-
ent with previously reported kinetics of dopaminergic
neuron differentiation [10,15]. Interestingly, we obtained
a similar proportion of TH expressing neurons from FACS
purified Sox1-GFP expressing neural progenitors as com-
pared to unsorted culture after re-plating on PA6 cells or
on PDL/laminin (Fig. 2A–C, Fig 3A), suggesting that SDIA
acts early during ES cell differentiation and that neural
progenitors in this differentiation paradigm are already
patterned to generate TH expressing neurons before or at
the time of Sox1 expression.
Since the production of neural progenitors during ES cell
in vitro differentiation is not synchronized, some of the
FACS purified cells might have been produced at an earlier
time point which have already committed to neuronal dif-
ferentiation and lost the competence to respond to SDIA
despite the maintenance of GFP expression. We have
therefore examined the early born neural progenitors by
performing FACS sorting at day 3–4 after plating. This is
the earliest time point when Sox1-GFP, nestin, and Sox1
expressing cells can be readily detected. We found that day
3–4  Sox1-GFPpos neural progenitors produced a similar
proportion of TH+ neurons as compared to day 7 neural
progenitors. (Fig 2D–E, 3C). Thus this data further sup-
ports the notion that the competence to generate TH
expressing neurons by neural progenitors is closely linked
to the onset of Sox1 expression.BMC Developmental Biology 2007, 7:86 http://www.biomedcentral.com/1471-213X/7/86
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Early specification of dopaminergic competent neural 
progenitors in the absence of SDIA or exogenous inductive 
molecules
To investigate whether the observed early dopaminergic
fate specification in Sox1  expressing neural progenitor
cells reflects a general mechanism or is specific for the PA6
differentiation method, we examined dopaminergic neu-
ron production in another differentiation paradigm:
monolayer differentiation. In contrast to previous reports
where few dopaminergic neurons are generated in the
absence of Shh and FGF8 [9,18], we found that a substan-
tial number of TH expressing cells are consistently and
robustly produced without feeder cells or the addition of
extrinsic factors during standard monolayer differentia-
tion in N2/B27 on gelatin-coated plastic (Fig 4 and 5).
Under these conditions, very few, if any, TH expressing
cells were present at 10 days of differentiation although
many β-III-tubulin expressing neurons can be detected at
this time (Fig. 4A). After another 4 days of differentiation
(a total of 14 days), more neurons (Fig 4B) and many TH
expressing cells can be detected (Fig. 4C), corresponding
to 16 ± 3% of the number of β-III-tubulin expressing neu-
rons. The TH expressing cells were frequently observed in
clusters and all had the morphology of neurons (Fig. 4C).
91 ± 7% of these TH expressing neurons also expressed
Nurr1.
To address whether the dopaminergic fate specification
also occurred already in the Sox1-GFP expressing neural
progenitors produced in monolayer differentiation, GFP
expressing cells were sorted using the same criteria as
described for PA6 cultures and re-plated on PDL/Laminin
coated plastics in N2B27 medium. Cell sorting was per-
formed after 7 days when 81 ± 9% of the cells expressed
GFP (Fig. 4D–F). Unsorted cultures processed in parallel
gave rise to TH expressing neurons at a frequency of 16 ±
3% (Fig. 4I, 5A). Again, re-mixed FACS purified GFPpos
and GFPneg populations produced a similar number of TH
FACS sorting of PA6-derived Sox1-GFPpos neural progenitors Figure 1
FACS sorting of PA6-derived Sox1-GFPpos neural 
progenitors. Neural progenitors generated by co-culturing 
ES cells with PA6 can be identified based on GFP reporter 
expression from the Sox1 locus (A, B). FACS plots showing 
the isolation of GFPpos neural progenitors from GFPneg ES cell 
differentiated progeny and PA6 cells (C – E). Gates were set 
based on plots of PA6 cells + wild type ES cells (C) and wild 
type ES cells alone (D). FACS sorting was performed either 
on day 7 (F) or day 3–4 (G). Sox1-GFPpos cells and GFPneg dif-
ferentiated ES cell population were subsequently cultured 
under neuronal differentiation conditions either on PDL/lam-
inin or in co-culture with PA6 cells. After a total of 14 days in 
cultures, cells were fixed and processed for immunocyto-
chemistry. FL1 = GFP, FL2 = PE, R2 = GFPpos neural progeni-
tors, R5 = GFPneg differentiated ES cells. Arrowhead points 
PA6-enriched cell population. Scale bar = 100 µm.
Generation of TH+ neurons by purified Sox1-GFP expressing  progenitors Figure 2
Generation of TH+ neurons by purified Sox1-GFP 
expressing progenitors. Neural progenitors generated by 
co-culture with PA6 were FACS purified at day 3 or day 7. 
Following re-plating and differentiation, cultures were fixed 
and double stained with antibody against β-III-tubulin (green) 
and TH (red). A similar number of TH expressing neurons 
was produced by PA6-derived progenitors after being re-
plated on PA6 (A) or PDL/Laminin (B) as compared to 
unsorted controls (C). Sox1-GFP expressing neural progeni-
tors purified at day 3–4 (D, D', D") generated a similar pro-
portion of TH expressing neurons as compared to those 
isolated at day 7 (E, E', E"). Scale bar = 100 µm.BMC Developmental Biology 2007, 7:86 http://www.biomedcentral.com/1471-213X/7/86
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expressing neurons to the unsorted controls (not shown).
The  Sox1-GFP expressing population gave rise to TH
expressing neurons (Fig. 4G–I) at a frequency indistin-
guishable from that of unsorted controls (14 ± 2% versus
16 ± 3%) after being re-plated on PDL/laminin (Fig. 5A),
suggesting that the ability to differentiate into TH express-
ing neurons by monolayer-derived progenitors is also
specified at the level of Sox1-GFP expression.
PA6/SDIA, but not monolayer differentiation, promotes 
formation of midbrain-like dopaminergic neuron 
progenitors and neurons
Midbrain property is key for functional integration of
transplanted dopaminergic neurons [19]. Previous studies
suggest that ES cell derived dopaminergic neurons are het-
erogeneous with regard to regional identities and only a
proportion of ES cell-derived TH+ neurons are characteris-
tic of midbrain dopaminergic neurons [3,6,15,18,20].
Therefore we examined the acquisition of midbrain
dopaminergic progenitor fate and its relation to Sox1-GFP
expression during neuronal differentiation by co-culture
with PA6 stromal cells or on PDL/laminin.
We first validated the purity of FACS sorted Sox1-GFP neu-
ral progenitors for contamination of undifferentiated ES
cells using antibodies against Oct4 and Sox2. Very few
(less than 5%) of the Sox1-GFPpos cells, derived either
from PA6 co-culture or from monolayer differentiation,
co-expressed Oct4 (Additional file 1). As expected and
similar to neural progenitors residing in the proliferative
zone of the developing midbrain, more than 90% of the
Quantification of TH expressing neurons derived from PA6- formed progenitors Figure 3
Quantification of TH expressing neurons derived 
from PA6-formed progenitors. Sox1-GFP expressing 
neural progenitors generated by co-culture with PA6 sorted 
at day 3–4 or day 7 and allowed to differentiate for a further 
7 days under various conditions. No difference was observed 
in the number of neurons that expressed TH in unsorted 
control cultures, reconstituted cultures, sorted GFPpos cells 
re-placed onto PA6 or onto PDL-Laminin coated plastic (A) 
or when plated back onto different coatings or feeder cells 
(B). Likewise, no difference was found in the generation of 
TH expressing neurons between neural progenitors sorted 
at day 3–4 and day 7(C).
Generation of TH+ neurons via monolayer differentiation Figure 4
Generation of TH+ neurons via monolayer differenti-
ation. A substantial number of neurons start to appear after 
10 days of monolayer differentiation (A). After 14 days of dif-
ferentiation, more mature neurons can be detected (B) and 
some also express TH expressing (C). Scale bar = 100 µm. 
Monolayer-derived neural progenitors were identified and 
isolated based on GFP expression (D-F). TH expressing neu-
rons were generated after a total of 14 days of differentiation 
when cells were plated on PDL/laminin (G), in co-culture 
with PA6 cells (H) after sorting as well as in control cultures 
(I).
Quantification of TH expressing neurons derived from mon- olayer-formed progenitors Figure 5
Quantification of TH expressing neurons derived 
from monolayer-formed progenitors. Sox1-GFP 
expressing neural progenitors were sorted from day 7 mon-
olayer cultures and allowed to differentiate for a further 7 
days under various conditions. No differences was found in 
the proportion of TH expressing cells generated by unsorted 
control cultures, sorted GFPpos neural progenitors re-placed 
on PA6 or PDL-Laminin coated plastic (A). In unsorted con-
trol cultures, the number of TH expressing neurons 
increased when SHH/FGF8 was applied during differentiation. 
However, addition of SHH/FGF8 to purified Sox1-GFP cells 
had no effect on the number of TH expressing neurons pro-
duced.BMC Developmental Biology 2007, 7:86 http://www.biomedcentral.com/1471-213X/7/86
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Sox1-GFP expressing cells also expressed Sox2 (Additional
file 1).
We found that a proportion of the PA6 co-culture derived
neural progenitors express midbrain markers including
FoxA2 (Fig. 6A), En1 (Fig. 6B), and Lmx1a (Fig. 6C). In
keeping with developmental studies, postmitotic mid-
brain DA precursor markers such as Nurr1 and Pitx3 were
not detected in the Sox1-GFPpos population. However,
after an additional 7 days of neuronal differentiation,
either on PDL/Laminin (Fig. 6E,H,K) or maintained in
contact with PA6 (Fig. 6D,G,J), these Sox1-GFPpos progen-
itors gave rise to cells that expressed Nurr1, Pitx3, and En1
(Fig. 6D,E,G,H,J,K). Pitx3 expressing cells always co-
expressed TH (inset in Fig 6E). Nurr1 and En1 were often,
but not always, co-expressed with TH (Inset in Fig 6H and
6K). In PA6-derived cultures, the proportion of TH
expressing cells that also expressed Nurr 1, En1 or Pitx3
was similar regardless of subsequent differentiation con-
dition after FACS sorting: 82% (PA6-differentiated, n =
102) and 86% (PDL/laminin-differentiated, n = 111) of
the TH expressing cells also expressed Nurr1, 20% (PA6-
differentiated, n = 98) and 24% (PDL/laminin-differenti-
ated, n = 103) co-expressed En1, and 16% (PA6-differern-
tiated, n = 100) and 14% (PDL/Laminin-differentiated, n
= 99) co-expressed Pitx3.
Similar to the PA6 derived progenitors, Sox1-GFPpos pro-
genitors obtained by monolayer differentiation co-
expressed Sox2 but not Oct4 (Supplemental Fig. 1). The
majority of monolayer-derived TH expressing neurons,
either produced from FACS purified Sox1-GFP progenitors
re-plated on PA6 cells or directly from unsorted control
cultures, expressed post mitotic dopaminergic neuron
precursor marker Nurr1 (Fig. 6F, M–O). However, very
few, if any, displayed a midbrain character at the level of
Sox1-progenitor stage as determined by the lack of expres-
sion of FoxA2, En1, and Lmx1a. Furthermore, markers
normally expressed by midbrain dopaminergic neurons
such as En1 and Pitx3 or by diencephalic or olfactory bulb
dopamine neurons such as Pax6, Nkx2.1, or Gad67 could
not be detected in monolayer derived TH expressing neu-
rons under any differentiation conditions tested (Fig. 6I,L
and data not shown). Thus, our data demonstrate that
neural progenitors produced from PA6 co-cultures can
differentiate into dopaminergic neurons with midbrain
characteristics, whilst monolayer differentiation paradigm
does not support the acquisition of a midbrain dopamin-
ergic neuron fate.
SDIA does not appear to have further instructive role or 
neurotrophic activity during neuronal differentiation
We noticed that the GFPpos cells plated on PDL/laminin or
matrigel coated plastic in the absence of PA6 cells gave rise
to TH expressing neurons at the same frequency as those
re-plated on PA6 (Fig. 3B). Furthermore, embryonic
mouse fibroblast cells (MEFs), which also exhibit some
SDIA activity [10], did not have an effect on the produc-
tion of TH+ neurons (Fig. 3B). Therefore, our data suggest
that SDIA does not promote terminal dopaminergic neu-
ronal differentiation. To further address this question, we
compared TH+ neuron production of FACS purified mon-
olayer derived Sox1-GFP progenitors re-plated either in
co-culture with PA6 cells or alone on PDL/laminin. We
found that a similar numbers of TH+ neurons were gener-
ated under both culture conditions independent of the
presence of PA6 cells at later stages of differentiation (Fig.
4G,H). 14 ± 2% of the neurons expressed TH when Sox1-
GFP progenitors were re-plated on PDL/Laminin (Fig.
5A), whilst a similar level (15 ± 3%) was obtained when
progenitors were re-plated in co-culture with PA6 cells
(Fig. 5A). Thus, while the overall frequency of dopamin-
ergic neuronal production by monolayer-derived neural
progenitors is significantly (p ≤ 0.05) lower than that of
PA6-formed progenitors, the exposure to SDIA during
later stages of neuronal differentiation has no effect on the
production of TH+ neurons. Similar results were obtained
when monolayer derived Sox1-GFP expressing progeni-
tors were sorted on day 3 of ES cell differentiation and
then plated on PA6 cells for the remainder of the differen-
tiation period. Taken together, our data showed that,
SDIA does not promote dopaminergic neuron differentia-
tion or maturation after Sox1-GFP expression.
To address whether monolayer-formed Sox1-GFPpos neu-
ral progenitors are able to respond to SHH and FGF8,
molecules well known to promote dopaminergic neuron
production in both mouse and human ES cells, we added
SHH and FGF8, together with FGF2 to cultures after FACS
sorting of monolayer-formed progenitors at concentra-
tions previously described to promote dopaminergic spec-
ification during ES cell differentiation [9,21]. While
continuous differentiation cultures under the same treat-
ment produced significantly more TH+ neurons (Fig. 5B,
and as reported previously [2,6,11,15], no increase in TH
expressing cells was observed from FACS purified neural
progenitors (Fig. 5B) and no midbrain dopaminergic
marker expression was induced within the TH expressing
population. Therefore, our results suggest that the compe-
tence for dopamine neuron differentiation is acquired
very early on during mouse ES cell in vitro development
and is in-separable from the establishment of a pan-neur-
oectodermal fate.
Discussion
Restorative cell therapy for Parkinson's disease, where
immature dopaminergic neurons are isolated from early
gestation foetuses and transplanted into the striatum of
PD patients, has been used with promising results [22].
However, to carry this approach forward and to circum-BMC Developmental Biology 2007, 7:86 http://www.biomedcentral.com/1471-213X/7/86
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vent ethical and practical issues associated with using pri-
mary foetal cells, an alternative strategy for obtaining
unlimited numbers of cells for grafting is essential. ES cells
constitute a promising source of such cells, but much
remains to be elucidated about how neurons derived from
ES cells are patterned as well as how and when they
acquire an anterior-posterior and dorsal-ventral identity
that allows them to differentiate into neurons with spe-
cific characteristics, such as midbrain dopaminergic neu-
rons.
Studies using primary cell grafts have shown that survival
of dopamine neurons in the host brain decreases with
developmental age of the donor tissue [23], suggesting
that when grafting dopamine neurons in PD models it is
important to use immature cells that survive the proce-
dure well. It is also essential that the cells grafted have
been sufficiently patterned so that they are capable of dif-
ferentiation into fully mature midbrain dopaminergic
neurons in the host brain. Thus, in order to use ES cells
derived neuronal precursors in transplantation experi-
ments, it is important to determine at what stage the cells
are sufficiently patterned to generate the correct pheno-
type in the host brain, but yet immature enough to survive
the grafting procedure.
Co-culturing with PA6 cells has been reported to be an
effective method for generating neurons from both mouse
and human ES cells [10,15,24,25]. Differentiation of
SDIA-treated ES cells in vitro appears to mimic the natural
course of in vivo neurogenesis as judged by the temporal
expression of neural progenitor and differentiated neuro-
nal markers [10]. No significant amount of mesodermal
cells are formed in this differentiation paradigm, and the
neuronal subtypes generated include that of forebrain,
midbrain and hindbrain although cells with characteris-
tics of spinal cord neurons has not been reported [10,26].
Of particular interest is that a significant portion of the
neurons generated express TH and a sub-portion also
express other markers characteristic of midbrain neurons
[10,15]. The PA6-derived neurons produce and release
dopamine and have been shown to functionally integrate
after intracerebral grafting [10,27]. Sox1-GFP expressing
cells purified from PA6 cultures also differentiate into
dopamine neurons after transplantation [16,17].
By utilizing the Sox1-GFP model system, where GFP faith-
fully mimics the expression of endogenous Sox1 in the
entire developing neuroepithelium during early develop-
mental stages and in neural progenitors in vitro [9,14,28],
we were able to determine at what stage SDIA acts during
ES cell differentiation, and to what extent regional identity
is acquired intrinsically in this model system as well as in
other ES cell differentiation paradigms. Sox1 is expressed
in all neural progenitor cells at early developmental time
Expression of midbrain markers by Sox1-GFP+ neural progen- itors and their differentiated progeny Figure 6
Expression of midbrain markers by Sox1-GFP+ neural 
progenitors and their differentiated progeny. Sox1-
GFPpos neural progenitors, generated by co-culture with PA6 
(A-C, D, E, G, H, J, K) or from monolayer culture (F, I, L-O), 
were purified by FACS. Cells were either collected onto 
slides by cytospin (A-C) or re-plated on PA6 or PDL/laminin 
and allowed for differentiation for a further 7 days (D-O). 
Cells collected on slides were examined for the expression 
of midbrain dopaminergic progenitor markers by immunos-
taining using antibodies against FoxA2 (A), En1 (B) and 
Lmx1a (C). Cultures were processed for the expression of 
midbrain dopaminergic neuron markers including Nurr1 (D-
F), En1 (G-I), and Pitx3 (J-L) in conjunction with TH (inset E, 
H, K). Nurr1, En1 and Pitx3 was detected in cells derived 
from PA6 formed progenitors (D, E, G, H, J, K) whereas only 
Nurr1 (F, M-O) was found to be expressed in cells derived 
from monolayer-derived neural progenitors. Scalebar for A-
C and M-O = 10 µm, scalebar for D, E, G, H, J, K = 50 µm 
and scalebar for F, I, L = 50 µm.
Expression of midbrain markers by Sox1-GFP+ neural progen- itors and their differentiated progeny Figure 6
Expression of midbrain markers by Sox1-GFP+ neural 
progenitors and their differentiated progeny. Sox1-
GFPpos neural progenitors, generated by co-culture with PA6 
(A-C, D, E, G, H, J, K) or from monolayer culture (F, I, L-O), 
were purified by FACS. Cells were either collected onto 
slides by cytospin (A-C) or re-plated on PA6 or PDL/laminin 
and allowed for differentiation for a further 7 days (D-O). 
Cells collected on slides were examined for the expression 
of midbrain dopaminergic progenitor markers by immunos-
taining using antibodies against FoxA2 (A), En1 (B) and 
Lmx1a (C). Cultures were processed for the expression of 
midbrain dopaminergic neuron markers including Nurr1 (D-
F), En1 (G-I), and Pitx3 (J-L) in conjunction with TH (inset E, 
H, K). Nurr1, En1 and Pitx3 was detected in cells derived 
from PA6 formed progenitors (D, E, G, H, J, K) whereas only 
Nurr1 (F, M-O) was found to be expressed in cells derived 
from monolayer-derived neural progenitors. Scalebar for A-
C and M-O = 10 µm, scalebar for D, E, G, H, J, K = 50 µm 
and scalebar for F, I, L = 50 µm.BMC Developmental Biology 2007, 7:86 http://www.biomedcentral.com/1471-213X/7/86
Page 7 of 9
(page number not for citation purposes)
points but is cleared from the ventral midbrain by the
time dopamine neurons are generated during develop-
ment [13,28]. Therefore, whether midbrain dopaminergic
progenitors are derived from Sox1 expressing cells
remains unknown. Our study shows directly that TH
expressing neurons are indeed derived from the Sox1-GFP-
pos population, providing further support of using ES cell
model for lineage analysis [29,30]. The notion that mid-
brain progenitors are part of the Sox1-GFPpos population is
further supported by the fact that they also express Sox2,
En1, Lmx1a, and FoxA2.
Furthermore, we show unambiguously that SDIA acts at
an early stage of ES cell differentiation, most likely at the
level of neural progenitor formation since the cells are
already specified at the Sox1 expressing neural progenitor
stage. This conclusion is supported by data obtained with
both early born (day 3–4) and late born (day 7) Sox1-GFP-
pos neural progenitors. During ES cell differentiation Sox1-
GFP expression precedes that of nestin [14], lending fur-
ther support to our notion. After the neural progenitor
stage, SDIA can no longer direct the formation of
dopaminergic neurons or act as a survival factor during
neuronal differentiation. Early specification of ES cell-
derived neural progenitors also seems to be the case for
telencephalic fates, as the first 5 days of the induction
period is decisive in telencephalic specification during ES
cell differentiation in a similar, but feeder free, culture sys-
tem [26]. It is interesting to note that this early specifica-
tion seems to be a general feature of dopaminergic
differentiation from ES cells, as we obtained the same
result in a monolayer culture system that is not dependent
on feeder cells or the addition of extrinsic patterning mol-
ecules. Thus, fate specification and progenitor formation
may occur concurrently and may be instructed by the
same signals, suggesting that neuronal specification and
fate determination during ES cell differentiation are two
closely linked processes that may not always be uncou-
pled. This phenomenon is to some extent different from
neural progenitors in the embryo since an alternative
regional identity of neural tissues can be induced by mor-
phogenes when applied within a certain developmental
time window [31].
However, it would be interesting to investigate whether a
similar fast track fate specification also occur in human ES
cells where the generation of any given cell type takes
much longer time than the mouse counterpart. In this
regard it is worth mentioning that ES cell-derived neural
progenitors appears to have a wider time window of com-
petence to adopt posterior cell fates, such as spinal cord
identity [32], which is normally formed during a relatively
longer period of time during development.
The current study also presents the first report on robust
production of dopaminergic neurons using a monolayer
differentiation protocol without the need for feeder cells
or addition of extrinsic patterning molecules such as Shh
and Fgf8. Monolayer-derived TH expressing neurons co-
express Nurr1, a gene marker that is expressed in
dopaminergic neurons but its expression is excluded from
other catecholaminergic neurons [33]. Thus the TH+ neu-
rons generated are likely dopaminergic. However, these
cells do not express any additional markers characteristic
of a mesencephalic phenotype.
Approximately 25% of the dopaminergic neurons in the
central nervous system are located outside the midbrain.
Instead of En1 and Pitx3, these non-midbrain dopaminer-
gic neurons express other proteins characteristic of their
stereotypic position (reviewed in [34]). For example,
diencephalic dopamine neurons express Pax6, Dlx, and
Nkx2.1 and the dopaminergic neurons in the olfactory
bulb are GABA-ergic and also express Pax6 and Dlx [3,35-
37]. No Nkx2.1, Pax6 or Gad67 (marking GABA-ergic
neurons) expression was detected in our monolayer cul-
ture derived TH expressing neurons. Thus, these neurons
do not seem to bare characteristics for any specific
dopaminergic subtype. The lack of specific regional char-
acteristics might be due to limited inductive signals pro-
duced in monolayer differentiation conditions. In this
regard, it is worth mentioning that SHH and FGF do not
appear to have dopaminergic neuron promoting activity
in purified Sox1pos neural progenitors, despite the fact that
these molecules induce dopaminergic neuron production
in heterogeneous ES cell differentiation culture
[21,31,38]. Thus these inductive molecules either only
work during a narrow time window prior to or at the point
of Sox1 expression during ES cell development and/or act
in collaboration with unknown co-factors produced by
non-neural cells.
Conclusion
Detailed knowledge of the effects and timing of patterning
signals are essential for planning prospective strategies to
produce specific neuronal subtypes from ES cells. We
show that dopaminergic specification occurs early during
mouse ES cell differentiation and is tightly linked with the
acquisition of a pan neural fate. Our results suggest that
the time-window for dopaminergic specification is quite
narrow and that attempts to increase the number of
dopaminergic neurons should be focused on the early
neural induction stage during ES cell in vitro differentia-
tion than at later stages of neuronal differentiation.
Methods
Cell culture
Sox1-GFP ES cells were maintained in Glasgow Modified
Eagles Medium (GMEM) supplemented with 2-mercap-BMC Developmental Biology 2007, 7:86 http://www.biomedcentral.com/1471-213X/7/86
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toethanol, nonessential amino acids, sodium bicarbo-
nate, 10% fetal calf serum and leukemia inhibitory factor
(LIF) in gelatinized tissue culture flasks. Differentiation
on PA6 stromal cells was carried out as previously
described [10]. Briefly, ES cells were cultured on a layer of
PA6 stromal cells for 7 days in GMEM supplemented with
10% knock-out serum replacement (Gibco) at a density of
60 cells/cm2. At day 7 medium was replaced with N2B27
(StemCellSciences) for the remainder of the differentia-
tion period.
Monolayer differentiation was carried out as previously
described [8,9]. Briefly, ES cells were plated on gelatinized
tissue culture plastics in N2B27 at a density of 10 000
cells/cm2. Both types of differentiation cultures were proc-
essed for FACS either at day 3–4 or 7 followed by for
immunostaining at day 14.
FACS sorting
Cells were trypsinized and resuspended in 1% BSA in
phosphate buffered saline (PBS) and filtered using a cell
strainer (BD Falcon) to ensure single cell suspension. All
cell sorting experiments were performed on a MoFlo cell
sorter (DAKO). Live cells were gated based on forward
scatter and side scatter and/or by 7AAD dye exclusion.
Where applicable, the majority of the PA6 feeder cells
were excluded based on their differential appearance from
that of ES cell derivatives on PE (autoflouresence)/FITC
plot. Gates for the two cell populations were set using PA6
cells and differentiated parental E14TG2a ES cells (Figure
1C, D). In some experiments, PA6 cells were excluded
based on their inability to exclude 7-AAD. The GFPpos neu-
ral progenitor population and the GFPneg differentiated ES
cell fraction were collected and cell viability at the end of
the FACS sorting procedure was determined using trypan
blue dye exclusion method. FACS sorted cells were either
plated for neuronal differentiation or directly processed
for cytospin.
Neuronal differentiation
FACS sorted cells were re-plated either on Poly-D-
lysine(PDL)/Laminin coated plastics or on PA6 stromal
cells, at a density of 100 000 cells/cm2 in both cases.
Where indicated SHH (400 ng/ml, R&D), FGF8 (100 ng/
ml, R&D), and FGF2 (10 ng/ml. R&D) was added to the
N2B27 medium. At the end of the culture period, cells
were fixed in ice cold 4% paraformaldehyde (PFA) for 15
min at room temperature followed by 3 rinses in PBS.
Cytospin
FACS sorted cells were diluted to a concentration of 1 ×
105 cells/ml. 100 µl of cell suspensions of each sample
were spun at 1000 rpm for 4 minutes. Cells were immedi-
ately fixed in 4% PFA for 15 minutes at room temperature
followed by 3 rinses in PBS.
Immunostaining
Fixed cells were blocked with 5% normal serum and 0.2%
triton X-100 for 1 hour followed by incubation overnight
with primary antibodies: rabbit anti-TH (1:1000, Pel
Freeze), mouse anti-TH (1:1000, chemicon or 1:500, Pel-
Freeze), mouse anti-β-III-tubulin (1:500, Babco), rabbit
anti-Pitx3 (1:500, gift of Dr. M Smidt), mouse anti-En1
(1:250, DSHB), rabbit anti-Nurr1 (1:500, SantaCruz),
goat anti-FoxA2 (1:200, santaCruz), rabbit anti-Lmx1a
(1:2000, M German), goat anti-Oct4 (1:200, santaCruz),
rabbit anti-Sox2 (1:200, chemicon). Cells were washed 3
times in PBS followed by incubation for 1–2 hours with
flourescence-labeled secondary antibodies (1:200, Jack-
son lab) and DAPI (1:1000).
Quantifications and statistical analysis
The number of positively stained cells was quantified by
counting 18 randomly selected fields per well correspond-
ing to more than 1000 neurons in total. Similarly, the
number of TH expressing cells that also co-expressed
another marker was quantified by counting the total
number of TH expressing cells and the proportion of these
cells that also express another marker (Nurr1, Pitx3, En1).
3 wells per experiment were counted and the analysis was
repeated 3–4 times for each condition. Analysis of vari-
ance (ANOVA) was used to compare means between
groups. Differences between groups were determined
using the Bonferroni Dunn test, with P-values less than
0.05 considered statistically significant.
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